Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B.

1. Bonnet, R. (2003). Growing group of extended-spectrum blactamases: the CTX-M enzymes. Antimicrobial Agents and Chemotherapy 48, 1–14. 2. Mushtaq, S., Woodford, N., Potz, N. et al. (2003). Detection of CTX-M-15 extended-spectrum b-lactamase in the United Kingdom. Journal of Antimicrobial Chemotherapy 52, 528–9. 3. Baraniak, A., Fiett, J., Hryniewicz, W. et al. (2002). Ceftazidimehydrolysing CTX-M-15 extended-spectrum b-lactamase (ESBL) in Poland. Journal of Antimicrobial Chemotherapy 50, 393–6. 4. Mavroidi, A., Tzelepi, E., Miriagou, V. et al. (2002). CTX-M-3 blactamase-producing Escherichia coli from Greece. Microbial Drug Resistance 8, 35–7. 5. National Committee for Clinical Laboratory Standards (2001). Performance Standards for Antimicrobial Disk Susceptibility Tests: Approved Standard M2-A7. NCCLS, Wayne, PA, USA. 6. Tzelepi, E., Magana, C., Platsouka, E. et al. (2003). Extendedspectrum b-lactamase types in Klebsiella pneumoniae and Escherichia coli in two Greek hospitals. International Journal of Antimicrobial Agents 21, 285–8. 7. Jalaluddin, S., Devaster, J. M., Scheen, R. et al. (1998). Molecular epidemiological study of nosocomial Enterobacter aerogenes isolates in a Belgian hospital. Journal of Clinical Microbiology 36, 1846–52. 8. Olsen, J. E. (1990). An improved method for rapid isolation of plasmid DNA from wild-type gram-negative bacteria for plasmid restriction profile analysis. Letters in Applied Microbiology 10, 209–12. Journal of Antimicrobial Chemotherapy DOI: 10.1093/jac/dkh337 Advance Access publication 1 July 2004